Solasta Bio key facts
- Developer of biological pesticides and insect control products designed to provide superior natural crop protection.
- Solasta Bio’s last known valuation is $32.4M.
- It has raised $20.2M; the latest was Early Stage VC ($13.9M) in Aug 2024.
- Notable investors include Innovate UK, Scottish Enterprise, Future Planet Capital, StartLife, UK Innovation & Science Seed Fund — 17 tracked in total.
- Status: Privately Held (backing).
Who backs Solasta Bio
17+- ·The complete investor list: 17 names
- ·Watch Solasta Bio: the Monday email on marks, rounds and moves
Solasta Bio funding rounds
No funding rounds for Solasta Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Solasta Bio valuation
Solasta Bio's last known valuation is $32.4 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
Solasta Bio investors
17 investors are on record for Solasta Bio, including Innovate UK, Scottish Enterprise, Future Planet Capital and StartLife. By type, the record holds 6 venture capital firms and 1 growth equity firm.
About Solasta Bio
Developer of biological pesticides and insect control products designed to provide superior natural crop protection. The company's product portfolio includes biological pesticides and neuropeptide-based insect control products that control a wide spectrum of pests, including those resistant to synthetic chemistries, enabling farmers to manage pests and insects and improve crop production in a safe, sustainable and eco-friendly manner.
- Sector
- Materials and Resources
- HQ
- Glasgow, United Kingdom
- Founded
- 2020
- Employees
- 37
- Website
- solastabio.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Solasta Bio’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.